How Standard Drug Test Panels Work
Drug test panels are designed to detect the presence of substance classes — not specific brand-name drugs. A standard urine panel typically screens for categories such as amphetamines, opiates, benzodiazepines, cannabinoids, and cocaine metabolites. Because of this, a prescription medication that falls into one of those chemical categories may register as a positive result on an initial screen — even if the person is taking it exactly as prescribed.
This is one of the primary reasons Medical Review Officers (MROs) exist. An MRO is a licensed physician who reviews positive results and contacts the donor to determine whether a legitimate prescription could explain the result. Without MRO review, a positive caused by a prescription may be indistinguishable from one caused by non-prescribed use. DOT drug testing programs require MRO review; many non-DOT workplace programs add it by choice.
Prescription Medications That May Affect Drug Test Results
The medications listed below are commonly associated with potential cross-reactivity or detection on standard drug test panels. This is not an exhaustive list, and test results can vary based on the specific panel used, the laboratory, the cutoff levels, the dose, and individual metabolism. If you take any prescription medication, inform your MRO or testing coordinator before your test.
Amphetamine-Based ADHD Medications
Medications prescribed for ADHD — such as amphetamine salts (Adderall, Vyvanse) and methylphenidate (Ritalin, Concerta) — may show up on a standard drug panel. Amphetamine-based medications in particular are chemically similar to what panels screen for and may register as a positive for amphetamines. The result does not mean the medication was misused — it may simply reflect that the substance is present in the system.
Common brand names that may be relevant: Adderall, Vyvanse, Dexedrine
Opioid Pain Medications
Many prescription pain medications belong to the opioid or opiate class of drugs — the same class that standard panels are designed to detect. If you take prescription opioids for pain management, those medications may appear on a drug test result. Whether a positive result is reportable to an employer depends on whether a valid prescription can be verified through MRO review.
Common brand names that may be relevant: Vicodin (hydrocodone), Percocet (oxycodone), Tylenol with Codeine, tramadol, OxyContin
Benzodiazepines for Anxiety or Sleep
Benzodiazepines are a class of medication commonly prescribed for anxiety, panic disorders, and sleep difficulties. Standard drug panels often screen for benzodiazepines, so a prescription in this category may potentially trigger a positive result.
Common brand names that may be relevant: Xanax (alprazolam), Valium (diazepam), Klonopin (clonazepam), Ativan (lorazepam), Restoril (temazepam)
Certain Antidepressants
Most antidepressants — particularly SSRIs such as Prozac, Zoloft, and Lexapro — are generally not known to cause positive results on standard panels. However, bupropion (commonly sold as Wellbutrin) has been associated with potential false positive results for amphetamines in some testing scenarios. Results can vary by lab and testing methodology.
Common brand names that may be relevant: Wellbutrin (bupropion)
Sleep Medications
Some prescription sleep aids may have properties that overlap with substances screened on standard panels. Zolpidem (Ambien) has been associated with potential benzodiazepine-like readings on certain immunoassay screens in some cases, though this can vary by test type and laboratory.
Common brand names that may be relevant: Ambien (zolpidem)
Muscle Relaxants
Certain muscle relaxants may be detected on drug panels or metabolize in ways that could affect results. Carisoprodol (Soma) metabolizes into meprobamate, which some panels may detect. Results depend heavily on the specific panel and laboratory cutoff levels.
Common brand names that may be relevant: Soma (carisoprodol)
Medical Marijuana — Legal States
In Illinois and other states where medical and recreational marijuana is legal, cannabis use is still detectable on a standard drug test panel. A positive THC result does not distinguish between legal and illegal use — the substance is simply present in the system. Employers in Illinois maintain the right to enforce drug-free workplace policies regardless of legal status in most circumstances. If you hold a valid medical marijuana card, this should be disclosed to your MRO if a positive result occurs.
Over-the-Counter Medications and Supplements
It is worth noting that some non-prescription medications and supplements have also been associated with potential cross-reactivity on certain test panels. These can include some cold medicines, diet supplements, and herbal products. If you regularly take any OTC products and are concerned about your results, discuss this with your physician or testing coordinator before your test.
What Employees Should Do Before a Drug Test
If you take any prescription medication and have an upcoming drug test, consider taking the following general steps:
- Do not stop taking prescribed medication without consulting your physician first
- Inform the MRO — if your program includes MRO review, the MRO will contact you if a result requires verification. Be prepared to provide documentation of your prescription.
- Ask your employer whether their program includes MRO review before the test takes place
- Do not assume a positive result will automatically be reported — MRO review exists specifically to evaluate these situations
- Consult your physician if you have concerns about how a specific medication may interact with a specific test type
What Employers Should Know
For employers running non-DOT drug testing programs, MRO review is not legally required — but it is strongly recommended for any workforce where employees may take prescription medications. Without MRO review, a positive result caused by a legitimate prescription may be indistinguishable from one caused by non-prescribed use, and any employment action taken on that result may not be legally defensible.
Adding MRO review to a non-DOT program typically costs $15–$25 per test and ensures every reported positive has been evaluated by a licensed physician before you take action.
For questions about setting up a non-DOT program with MRO review, call us at (219) 315-0345 or visit our non-DOT drug testing page. See also our employer FAQ and the resources hub.
